Oct 11
|
2 Top Dividend Stocks to Buy Hand Over Fist Right Now
|
Oct 10
|
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
|
Oct 9
|
2 Biotech Stocks to Buy Hand Over Fist in October
|
Oct 8
|
Amgen and MediLink to collaborate on SCLC combination therapy
|
Oct 8
|
Want to Invest in the Weight Loss Boom? Consider Buying These 2 Stocks
|
Oct 7
|
Insiders At Amgen Sold US$4.0m In Stock, Alluding To Potential Weakness
|
Jul 30
|
Amgen (AMGN) Expected to Beat Earnings Estimates: Should You Buy?
|
Jul 29
|
Wall Street is still jittery on GLP-1s
|
Jul 29
|
Should We Be Delighted With Amgen Inc.'s (NASDAQ:AMGN) ROE Of 75%?
|
Jul 29
|
NewAmsterdam heart drug hits trial goal, but data appear to disappoint investors
|
Jul 25
|
Amgen (AMGN) Stock Moves -0.39%: What You Should Know
|
Jul 25
|
Amgen Surges As Weight-Loss Trials Drive Excitement
|
Jul 24
|
What Lies in Store for Healthcare ETFs in Q2 Earnings?
|
Jun 25
|
Why Amgen (AMGN) Outpaced the Stock Market Today
|
Jun 25
|
Top Stock Reports for Chevron, Amgen & Philip Morris
|
Jun 25
|
BMS expands Krazati’s FDA label to include colorectal cancer
|
Jun 25
|
Biotech ETF (BBH) Hits New 52-Week High
|
Jun 21
|
The 30-stock secret: ‘Don’t fight Papa Dow’
|
Jun 20
|
Amgen (AMGN) Gains As Market Dips: What You Should Know
|
Jun 20
|
Where Will Amgen Be in 5 Years?
|